Major histocompatibility complex (MHC) tetramer technology: an evaluation. - Wikidata - awgldk - TriplyDB

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

http://www.wikidata.org/entity/Q34984510

about

Proteomics in cancer vaccine development.Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.MHC-bound antigens and proteomics for novel target discovery.A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population Nanosystems for simultaneous imaging and drug delivery to T cells Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes.HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.Antigen-specific killer polylactic-co-glycolic acid (PLGA) microspheres can prolong alloskin graft survival in a murine model.

P2860

Q33215044-93268FAE-2FBF-442B-9412-601A76B6B4AB Q34139182-F92AEF67-E918-4BA2-8430-217EEBBE31B0 Q35911151-10B59C88-FE82-41B2-9548-48A9741B4E5A Q36788055-39727014-9CCD-4C0B-89CD-0D1D343A8BB3 Q36871937-E1008648-1E09-4699-90E2-C522462D0A4A Q38877091-CFA244D6-CBC6-4C5A-B2D6-203A5042F70D Q38949927-2DB38BA0-B3E1-4CB3-BCE0-9E5260C6D0E4 Q40975411-DF45E454-F787-4870-B7D6-2A443CF06649

P2860

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

http://www.wikidata.org/entity/Q34984510

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

@ast

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

@en

type

label

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

@ast

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

@en

prefLabel

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

@ast

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

@en

P1433

Q34984510-D7E0C028-9D33-4226-8FD9-C93E79B44BC7

P1476

Q34984510-5345ADBA-3365-468D-9A6B-38684B1B43D2

P2093

Q34984510-1A0DED19-C1A1-44BD-AE25-80EF0A59C74C

Q34984510-2187F3C6-0D32-4F25-937F-1B9615762AAF

Q34984510-36D853AB-B48D-4B8B-832F-3102FECCD6B8

Q34984510-B9C0416B-D16D-4245-993F-42DE2544CA54

P2860

Q34984510-1262BDC7-D3FB-4D9D-ABA2-EF8BC9C5CC04

Q34984510-150D350E-74B7-49AE-B3AB-501C6364BC86

Q34984510-18034C0E-DE9A-448A-8A46-57FE60EA7E5A

Q34984510-1F6C5206-4984-4AE9-B847-A31A1F1FBBA5

Q34984510-1F835812-C2C3-4EDF-B8AF-6C8B75797DB4

Q34984510-237C5FE4-6FCA-4788-A85B-DEB3FFC2357E

Q34984510-250B82A7-5653-4449-9C1A-AC6E6F741722

Q34984510-26915238-2F5B-44EE-A3B7-B8976A5DAE6A

Q34984510-27334546-1957-455B-8289-B41939DBFE35

Q34984510-2B2B7BB0-677F-47CE-ACC2-51B22A331C5D

P304

Q34984510-57BE7FC3-62FE-4920-94B3-B33FCB64ED20

P31

Q34984510-222E82FD-079F-460B-8860-BE4F5862BAAF

P356

Q34984510-6F18EB12-7E0E-4B8D-B150-70DB048D3E2B

P407

Q34984510-D91BADFE-A933-43DB-81B4-D838769BECEA

P433

Q34984510-FA968AEB-E9A0-45D4-83CF-F630D803A482

P478

Q34984510-6F6E88A3-60D8-479A-81F0-600797398C66

P577

Q34984510-1A3707BB-DA90-46B1-9A65-DADC252CC3BB

P698

Q34984510-DF42BC41-06A7-4006-8D20-6572F25F5562

P356

1099800402238332

P1433

Biological Research for Nursing

P1476

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

@en

P2093

Carolyn M Constantin

http://www.w3.org/2001/XMLSchema#string

Elizabeth E Bonney

http://www.w3.org/2001/XMLSchema#string

John D Altman

http://www.w3.org/2001/XMLSchema#string

Ora L Strickland

http://www.w3.org/2001/XMLSchema#string

P2860

Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven

Phenotypic analysis of antigen-specific T lymphocytes

Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix

The dynamics of HTLV-I and the CTL response.

Divided we stand: tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester.

Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Accessing complexity: the dynamics of virus-specific T cell responses.

Progress in human tumour immunology and immunotherapy.

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

Tracking T cells with tetramers: new tales from new tools.

P304

115-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1099800402238332

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12408217

http://www.w3.org/2001/XMLSchema#string